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Background: Polydipsia frequently occurs in schizophrenia patients. The excessive water loading in polydipsia
occasionally induces a hyponatremic state and leads to water intoxication. Whether polydipsia in schizophrenic
patients correlates with neuropsychological impairments or structural brain changes is not clear and remains
controversial.
Methods: Eight polydipsic schizophrenia patients, eight nonpolydipsic schizophrenia patients, and eight healthy
controls were recruited. All subjects underwent magnetic resonance imaging (MRI) and neuropsychological testing.
Structural abnormalities were analyzed using a voxel-based morphometry (VBM) approach, and patients’
neuropsychological function was assessed using the Brief Assessment of Cognition in Schizophrenia, Japanese
version (BACS-J).
Results: No significant differences were found between the two patient groups with respect to the clinical
characteristics. Compared with healthy controls, polydipsic patients showed widespread brain volume reduction
and neuropsychological impairment. Furthermore, the left insula was significantly reduced in polydipsic patients
compared with nonpolydipsic patients. These nonpolydipsic patients performed intermediate to the other two
groups in the neuropsychological function test.
Conclusions: It is possible that polydipsia or the secondary hyponatremia might induce left insula volume
reduction. Furthermore, this structural brain change may indirectly induce more severe neuropsychological
impairments in polydipsic patients. Thus, we suggest that insula abnormalities might contribute to the
pathophysiology of polydipsic patients.
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in schizophreniaBackground
Schizophrenia affects about 1% of the population world-
wide [1], and induces neuropsychological impairment [2],
as well as structural brain changes [3]. Among the many
comorbidities associated with schizophrenia, polydipsia is
defined as either chronic or intermittent ingestion of large
volumes of water. Polydipsia occurs frequently among
patients with schizophrenia and may be present in more
than 20% of chronic psychiatric inpatients [4]. Polydipsia
is not explained by medically induced polyuria, but it
may lead to hyponatremic symptoms and can cause* Correspondence: tomo-n@nirs.go.jp
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distribution, and reproduction in any mediumneurological symptoms. These neurological symptoms in-
clude: nausea, vomiting, delirium, ataxia, seizures, and
even death, and are often referred to as “water intoxica-
tion” [4]. Up to 5% of chronic inpatients develop water in-
toxication, although mild cases may go undetected [4].
Neuroendocrine studies revealed that schizophrenia
patients with hyponatremia secreted excess antidiuretic
hormone (ADH) in a hypo-osmolemic serum state [5,6].
ADH controls the reabsorption of water molecules in
the tubules of the kidneys and plays a key role in the
regulation of water. Therefore, excessive ADH secretion
may accelerate a hyponatremic state and produce water
intoxication [6,7]. The pathophysiology of polydipsia on
the other hand remains to be elucidated.tral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
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sic hyponatremic schizophrenia patients present with vo-
lume reductions in the anterior medial temporal lobe
[8,9], especially in the anterior hippocampus relative to
nonpolydipsic schizophrenia using region of interest
(ROI) analysis [10]. Indeed, one study reported that
polydipsic, hyponatremic schizophrenia patients exhibi-
ted bilateral inward deformations in the anterior lateral
hippocampal surface [11]. However, structural differences
in other brain regions of these polydipsic hyponatremic
schizophrenia patients were not assessed. Interestingly,
hyponatremic patients presented with poorer neuro-
psychological functioning compared to patients without a
water imbalance [12-15]. Polydipsic hyponatremic schizo-
phrenia patients scored lower on the Mini-Mental State
Examination (MMSE) [14] with significant impairments
in visual memory and information processing [12],
intelligence, learning/memory, and facial discrimination
[15] compared to control patients. Thus, it is considered
that the structural changes in the anterior hippocampus,
as well as in the associated prefrontal/limbic brain
regions contribute to the underlying pathophysiology in
polydipsic hyponatremic schizophrenia [11,15]. To our
knowledge, these brain regions have not been examined
using voxel-based morphometry (VBM) [16] in polydip-
sic schizophrenia patients. VBM is an efficient whole
brain unbiased technique capable of analyzing structural
magnetic resonance images (MRI), such as the differences
between brains of schizophrenia patients with or with-
out water imbalances. Lastly, previous studies [15] have
not evaluated executive functions, which are impaired in
schizophrenia [17-20], nor have they included healthy
control subjects.
To assess the pathophysiology of polydipsic schizo-
phrenia (PS), we used the VBM approach and evaluated
neuropsychological function, including executive func-
tions, to compare the difference between PS, nonpoly-
dipsic schizophrenia (NS) and healthy controls (HC).
In the VBM analysis, the main aim of this study was to
compare brain structural volumes between PS and NS.




Patients were recruited from among inpatient and out-
patient facilities at the Nara Medical University Hospital
and affiliated hospitals. The patients fulfilled the Diag-
nostic and Statistical Manual of Mental Disorders, 4th
edition (DSM-IV) criteria for schizophrenia. Similar to a
previous study [21], the diagnosis of polydipsia was
made when the patient was observed to consistently
drink excessive quantities of fluid by the hospital staff or
the patients’ family. To ensure the validity of a diagnosisof polydipsia, we limited our study to only those patients
with a history of polydipsic episodes and low serum so-
dium levels (less than 135 mEq/L) spanning at least the
three most recent years per medical records. Therefore,
all PS patients had a history of both excessive fluid in-
take and hyponatremia within three years. Research psy-
chiatrists confirmed that these patients’ hyponatremia
was associated with polydipsia and was not attributable
to medical disorders such as hypothyroidism, or cardiac,
renal, or hepatic failure, or to medications such as diure-
tics or carbamazepine. The latter, carbamazepine, can
induce hyponatremia via the syndrome of inappropriate
antidiuretic hormone secretion (SIADH) [22]. We defined
PS as patients with a history of at least two hyponatremic
states induced by polydipsia on available records, and who
were continuously treated with water restrictions even on
the day of testing because of their excessive fluid intake
but who were not isolated from sources of water supply.
In summary, PS was diagnosed based not only on a history
of hyponatremia and excessive drinking fluid spanning the
three most recent years but also on the patients’ current
treatment situation (e.g., restriction of drinking excessive
quantity of fluid). NS had no history of polydipsia or
serum sodium levels lower than 135 mEq/L. One expe-
rienced psychiatrist assessed the severity of symptoms
using Positive and Negative Syndrome Scale (PANSS)
[23]. As presented in detail in Table 1, eight male right-
handed PS (43.75 ± 6.58 years) and eight male right-
handed NS (43.63 ± 7.67 years) were enrolled in this study.
All of these patients were inpatients, except one PS and
two NS. The frequency of hyponatremic states was 5.1 ±
2.9 times on available records, and the duration of poly-
dipsia was 8.4 ± 4.7 years in PS group. For comparison,
eight male right-handed HC (44.75 ± 3.77 years) patients
were recruited from the community in Nara by word of
mouth. Exclusion criteria for all participants were: any
current neurological disorders, a family history of inherit-
able neurological disorders, and a history of head injury
resulting in loss of consciousness, as well as alcohol or
substance abuse. This study was approved by the Ethics
Committee of the Nara Medical University. After a
complete description of the study to each participant,
written informed consent was obtained. To help rule out
the possible effects of hydration status on whole brain
volume [24] and neuropsychological functioning [15],
plasma osmolalities were obtained on the day of testing.
All participants were administered MRI and neuropsycho-
logical tests on the same day at Nara Medical University.
MRI acquisition and processing
Three-dimensional T1-weighted images were obtained
on a 1.5 T MRI machine (Magnetom Sonata, Siemens
AG, Erlangen, Germany) at Nara Medical University. All
slices were sagittal slices across the entire brain with a
Table 1 Demographic and clinical characteristics
mean ± S.D. PS (n = 8) NS (n = 8) HC (n = 8) Mann-Whitney U or Kruskal-Wallis p-value
Age [years] 43.75 ± 6.58 43.63 ± 7.67 44.75 ± 3.77 0.74 0.69
Body height [cm] 167.35 ± 5.24 170.04 ± 6.70 170.25 ± 4.65 1.76 0.414
Body weight [kg] 64.31 ± 7.94 70.48 ± 22.25 70.13 ± 8.36 2.4 0.302
Education [years] 13.38 ± 2.77 14.25 ± 1.58 14.38 ± 2.00 0.49 0.784
Posm [mmol/kg] 287.32 ± 11.82 289.57 ± 3.77 288.50 ± 4.04 0.64 0.727
Duration of illness [years] 20.38 ± 7.41 13.31 ± 9.63 - 17 0.114
No. of polydipsic episodes 5.1 ± 2.9 - -
Duration of polydipsia [years] 8.4 ± 4.7 - -
CPZ equi [mg/day] 859.38 ± 520.68 525.0 ± 287.85 - 21.5 0.269
PANSS Positive 17.5 ± 1.85 17.38 ± 3.20 - 33 0.913
PANSS Negative 26.13 ± 2.8 25.38 ± 1.41 - 30.5 0.871
PANSS General 48.63 ± 2.62 47.38 ± 2.62 - 23.5 0.365
S.D. standard deviation, PS polydipsic schizophrenia, NS nonpolydipsic schizophrenia, HC healthy controls, Posm plasma osmolality, CPZequi chlorpromazine
equivalents, PANSS positive and negative syndrome scale.
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time = 3.93 ms, flip angle = 15°, field of view = 230 mm,
slice thickness = 1.25 mm without gap, and a matrix
size = 512 × 512.
Image analysis was performed using statistical para-
metric mapping (SPM) 5 software (http://www.fil.ion.ucl.
ac.uk/spm/software/spm5/) developed in the Wellcome
Department of Imaging Neuroscience, Institute of Neur-
ology, University College London, running in MATLAB
7.8.0 (Mathworks, Sherborn, MA, USA).
VBM in SPM5 combines tissue segmentation, bias
correction, and spatial normalization into a unified
model [25] using default parameters. Individual brains
were normalized to tissue probability maps provided by
the International Consortium for Brain Mapping—East
Asian brains. Segmented gray matter (GM), white matter
(WM) and cerebrospinal fluid (CSF) images in native
spaces were used to check the segmentation in that space
and to measure total intracranial volume (TIV). Modu-
lated normalized GM and WM images were tested for
voxelwise differences in the relative volume of GM and
WM. After segmentation, the GM and WM images were
smoothed to a full-width half maximum Gaussian kernel
of 8 mm.
Neuropsychological test
The Brief Assessment of Cognition in Schizophrenia
(BACS) [26] is an instrument that assesses multiple
aspects of cognition. The domains of neuropsychological
functions evaluated by the BACS are verbal memory,
working memory, motor speed, verbal fluency, attention/
speed of processing, and executive function. The Brief
Assessment of Cognition in Schizophrenia, Japanese
version (BACS-J) is Japanese version of BACS and has
been tested and shown to have reliability and validity[27]. The time required for BACS-J testing is about half
an hour. The same clinical psychologist administered
the BACS-J and gauged the neuropsychological func-
tions. The primary measure for each test in the BACS-J
was standardized by creating z-scores and setting the
HC mean to zero and the standard deviation to one. A
composite score was calculated by averaging all of the
six standardized primary measures from the BACS-J.
Statistical analysis
The Statistical Package for the Social Science (SPSS)
version 16.0 for Windows was used for statistical analysis
of demographic characteristics, clinical characteristics and
neuropsychological data. We used the Mann-Whitney U
test and Kruskal-Wallis test to determine statistical signifi-
cance. For multiple comparisons, post-hoc tests were
applied using the Dunnett T3 test. A significance level
at p = 0.05 was used.
VBM analysis using SPM5 was conducted for the
group comparisons between PS vs. NS and PS vs. HC.
Age and TIV were used as nuisance variables, and an
absolute masking threshold of 0.2 was used. Output was
in the form of SPM with the Montreal Neurological Insti-
tute (MNI) coordinates based on a height threshold of
p < 0.001 uncorrected and an extend threshold of 50
contiguous voxels. Neuroanatomical locations were
identified using the WFU Pick Atlas Tool (http://www.
ansir.wfubmc.edu/).
Results
Demographic and clinical characteristics
The comparisons of the three groups with respect to
demographic and clinical characteristics are presented in
Table 1. There were no differences in demographic and
clinical characteristics among the three groups. All
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day. PS had a longer duration of illness and higher chlor-
promazine equivalent doses than did NS, but there were
no significant differences between these two patient
groups. Also, psychopathological scores measured by
PANSS were not significantly different between these
two patient groups.Brain structural differences
PS versus NS
PS showed significantly reduced GM/WM volume in the
left insula compared with NS (Figure 1a, Table 2). No
significant increased regions were found in NS com-
pared with PS.Figure 1 Significant regional GM/WM volume reduction. (a) PS < NS. (b
contiguous voxels displayed on the MNI template (avg152T1). The right sid
coordinate in MNI space is indicated in each section.PS versus HC
PS showed widespread GM/WM volume reduction com-
pared with HC (Figure 1b, Table 2). No significant
increased regions were found in PS compared with HC.Neuropsychological differences
Neuropsychological scores are shown in Table 3. The
composite score was −2.57 ± 1.78 for PS, –1.69 ± 1.69 for
NS and 0.00 ± 0.95 for HC. PS group was significantly
more impaired than HC in all categories of BACS-J. Fur-
thermore, PS group was more impaired in all categories of
BACS-J than NS, although not significantly. NS group was
significantly more impaired than HC in motor speed,
attention/speed of processing, and executive function.) PS < HC.P < 0.001 uncorrected with an extent threshold of 50
e of each section represents the right side of the brain. The z
Table 2 Regional GM/WM volume changes
Between group comparison Decreased region MNI coordinates (mm) voxels t-value
X Y Z
PS < NS L insula −42 −22 0 73 6.58
PS < HC R inferior temporal gyrus 56 −52 −18 471 7.28
L superior temporal gyrus −58 −40 14 289 8.44
R superior temporal gyrus 58 8 2 89 6.89
L insula −38 −22 12 73 5.09
L medial frontal gyrus −2 50 −14 315 6.39
L inferior frontal gyrus −30 16 −14 94 5.67
R lingual gyrus 10 −78 −8 1055 6.93
R cuneus 4 −82 32 420 6.08
R parahippocampal gyrus 22 −28 −14 194 6.18
L uncus −22 −6 −38 75 5.20
R cerebellar posterior lobe 40 −66 −26 92 5.01
MNI Montreal Neurological Institute, PS polydipsic schizophrenia, NS nonpolydipsic schizophrenia, HC healthy controls, R right, L left.
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Discussion
This is the first study to assess brain structural changes
using the VBM approach and neuropsychological im-
pairment—including executive function—between PS,
NS, and HC. The current study demonstrated PS
showed significant volume reduction in the left insula
compared to NS. In imaging studies of schizophrenia,
the laterality of the insula volume reduction is inconsist-
ent—localization can be found on either the right side,
left side, or bilaterally [28]. In our study, there were no
significant differences in the clinical characteristics be-
tween the two patient groups. In particular, the PANSS
scores of PS and NS were almost similar, despite pre-
vious findings indicating that schizophrenia with poly-
dipsia were characterized by greater severity of illness
[29]. Therefore, the left-sided volume reduction seemed
to be attributable to either the polydipsia or the second-
ary hyponatremia in our study. The insula is a component
of the “limbic integration cortex” and is associated with
emotional and neuropsychological functions [30-32].
Although there were no significant differences inTable 3 Neuropsychological scores using the BACS-J
PS (n = 8) NS (n = 8)
verbal memory 21.0 ± 12.47 30.25 ± 8.31
working memory 15.38 ± 2.13 17.13 ± 5.62
motor speed 40.75 ± 13.18 52.75 ± 15.34
verbal fluency 29.75 ± 7.91 33.38 ± 13.64
attention/speed of processing 39.88 ± 9.72 46.75 ± 15.27
executive function 13.88 ± 3.80 15.50 ± 2.67
PS polydipsic schizophrenia, NS nonpolydipsic schizophrenia, HC healthy controls.neuropsychological scores between the patient groups,
the PS group was more impaired in all categories of the
BACS-J compared to the NS group. This may be due to
their reduced insula volume, which in turn may indi-
rectly affect neuropsychological function. Indeed, the
insula has extensive connections to many brain areas in-
cluding limbic regions [28]. It should be noted that
chronic hyponatremia may also be associated with psy-
chomotor and attention deficits [33,34]. Although in the
current study the PS group had normal hydration status
on the day of testing, it is possible that past or present
hyponatremia affects neuropsychological function.
In a preliminary exploration, we found that PS had
widespread GM/WM volume reduction and neuropsycho-
logical impairment compared to HC. It is well accepted
that fronto-temporal integration [35], prefrontal-parietal
networks [36], the fronto-parieto-occipital network [37]
and the cortical-thalamic-cerebellar-cortical circuit [38]
support a variety of neuropsychological functions. The
widespread GM/WM volume reduction of these brain
networks, as in PS, would result in neuropsychological
impairment. Previous research has indicated that poly-
dipsic hyponatremic patients had reduced anterior
hippocampi compared to nonpolydipsic patients [10]HC (n = 8) Kruskal-Wallis p-value post hoc
38.13 ± 8.95 8.3 <0.05 PS < HC
22.38 ± 3.78 9.1 <0.05 PS < HC
72.75 ± 9.68 14.4 <0.001 PS < HC, NS < HC
42.38 ± 6.78 6.1 <0.05 PS < HC
65.75 ± 10.32 12.8 <0.01 PS < HC, NS < HC
18.63 ± 1.19 10.2 <0.01 PS < HC, NS < HC
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with chronic hyponatremia [15]. The uncus is regarded
as the anterior region of the hippocampus [39] and is a
recognizable internal marker for dividing the hippo-
campus [40,41]. Although in this study the size of the
uncus was not significantly different between the two
patient groups, PS exhibited volume reductions in the
left uncus compared with HC. We recruited PS patients
who were treated with water restriction. These water
restrictions may act to decrease the hyponatremic status
frequency and may prevent further volume reduction of
the anterior hippocampus. In our study, PS showed
normal hydration status on the day of testing and normal
sized brain regions when compared to the other groups. It
has been previously reported that acute hyponatremia
induced by polydipsia results in cerebral edema [24].
Therefore, our findings could reflect the trait abnor-
malities of PS.
There are some limitations in the current study. The
first is the small sample size, which reflects the difficulty
of recruiting and studying polydipsic patients [10,15]. It
has been shown that longer duration of illness [42] and
greater intensity of antipsychotic treatment [43] are
probably associated with structural brain changes. Al-
though the duration of illness and the chlorpromazine
equivalent doses were not statistically different between
PS and NS, their variances were moderate given our
sample size. Therefore, we could not completely exclude
the possibility of these confounding effects. The second
limitation is that the participants in our study consisted
only of males. It should be noted that a previous study
found that polydipsic schizophrenics had a more fre-
quent history of alcohol abuse [29], which was one of
the exclusion criteria in our study. Thus, these factors
might limit the generalizability of our results. Further-
more, our PS patients had histories of hyponatremia, but
did not indicate continuous hyponatremia or were not
examined with frequent hydration state measurements.
Therefore, we could not identify if the hyponatremia or
the polydipsia had more influence on the structural
brain changes. To clarify this point, another study is
needed that assesses polydipsic patients without a
history of hyponatremia.
Conclusion
Finally, it is possible that polydipsia or the secondary
hyponatremia might induce a left insula volume reduc-
tion. Our findings provide insights on the pathophy-
siology of schizophrenic polydipsia. In addition, further
insula volume reductions might induce further neuro-
psychological impairments. In the future, another imaging
method like diffusion tensor imaging or functional imaging
may help elucidate the brain networks disrupted or the
extent of pathophysiology in polydipsia.Competing interests
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